India, May 6 -- High Tide Inc. (HITI) has announced that its German subsidiary, Remexian Pharma GmbH, reached record distribution levels this quarter, showcasing continued growth in Europe's largest medical cannabis market.
For the second fiscal quarter ending April 30, 2026, Remexian sold 7.6 tonnes of medical cannabis in Germany. This is the highest volume they've ever recorded in a single quarter, reflecting a 21 percent increase from the previous quarter and a 49 percent jump compared to the same time last year.
CEO Raj Grover remarked that this achievement underscores the effectiveness of their distribution model, which leverages Remexian's local operations and High Tide's extensive procurement know-how gained from over $2.2 billion ...